Peel Therapeutics: From Elephants, Trees And Honeybees To Cancer Therapeutics
Through Evolutionary Biology
Executive Summary
With $36m in seed funding under its belt, Peel Therapeutics is harnessing the power of Darwinian science as it advances a pipeline of cancer and anti-inflammation assets inspired by plant and animal kingdoms.
You may also be interested in...
Apellis Bounces Back After Needle Discontinuation Amid Syfovre Safety Concerns
Real-world cases of retinal vasculitis linked with Syfovre for geographic atrophy in age-related macular degeneration may have resulted from a material used in a specific filter needle, the US firm revealed, as analysts remained optimistic on the product.
Geron’s Imetelstat Headed To US FDA Advisory Committee For MDS
Geron’s telomerase inhibitor will also get standard review for transfusion-dependent anemia in adults with low- to intermediate-1 risk myelodysplastic syndromes (MDS), suggesting FDA reviewers may be less bullish on imetelstat’s clinical data than analysts have been.